Mountain Valley MD Holdings (FRA:20MP) ROCE % : -26.54% (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Mountain Valley MD Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Mountain Valley MD Holdings's annualized ROCE % for the quarter that ended in Sep. 2024 was -26.54%.

Mountain Valley MD Holdings ROCE % Historical Data

The historical data trend for Mountain Valley MD Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mountain Valley MD Holdings ROCE % Chart

Mountain Valley MD Holdings Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

-165.71

-39.15

-36.54

-26.25

-25.61

Mountain Valley MD Holdings Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															-20.13	-30.60	-29.85	-50.90	-26.54

Mountain Valley MD Holdings ROCE % Calculation

Mountain Valley MD Holdings's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	-2.172	/	( ( (11.447 - 0.403)	+	(6.094 - 0.175) )	/ 2 )
	=	-2.172	/	( (11.044	+	5.919)	/ 2 )
	=	-2.172	/	8.4815
	=	-25.61 %

Mountain Valley MD Holdings's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-1.6	/	( ( (6.453 - 0.192)	+	(5.956 - 0.16) )	/ 2 )
	=	-1.6	/	( ( 6.261	+	5.796 )	/ 2 )
	=	-1.6	/	6.0285
	=	-26.54 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Mountain Valley MD Holdings (FRA:20MP) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Mountain Valley MD Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of Mountain Valley MD Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Mountain Valley MD Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mountain Valley MD Holdings Inc (FRA:20MP) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

MVMDF:USA 20MP:Germany MVMD:Canada

Address

260 Edgeley Boulevard, Unit 4, Vaughan, ON, CAN, L6K 3Y4

Website

https://www.mountainvalleymd.com

Mountain Valley MD Holdings Inc is a Canada-based company. The firm along with its subsidiaries is engaged in implementing its Quicksome oral delivery technologies across a variety of molecules in nutraceutical, vaccine, and pharmaceutical drug applications. The Quicksome desiccation technology utilizes liposomes and other stabilizing molecules to encapsulate and formulate active ingredients into efficient product formats that are consumed orally.

Mountain Valley MD Holdings Headlines

No Headlines